Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies?
about
Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin AmyloidosisFirst European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathySixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAPEvolving landscape in the management of transthyretin amyloidosisGuideline of transthyretin-related hereditary amyloidosis for clinicians.Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosisFrequency of Cardiovascular Involvement in Familial Amyloidotic Polyneuropathy in Brazilian PatientsSurvival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry.Familial Transthyretin Amyloidosis with Variant Asp38Ala Presenting with Orthostatic Hypotension and Chronic Diarrhea.Familial Mediterranean fever--a review.Cardiac amyloidosis: the heart of the matter.Cardiac involvement in hereditary-transthyretin related amyloidosis.One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition.Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.Asp58Ala is the predominant mutation of the TTR gene in Korean patients with hereditary transthyretin-related amyloidosis.Cardiomyopathy in a Japanese family with the Glu61Lys transthyretin variant: a new phenotype.Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis.Gender-related risk of myocardial involvement in systemic amyloidosis.Genotype, echocardiography, and survival in familial transthyretin amyloidosis.Genotypic and phenotypic correlation in an Italian population of hereditary amyloidosis TTR-related (HA-TTR): clinical and neurophysiological aids to diagnosis and some reflections on misdiagnosis.Bone scintigraphy with99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosisMost recent common ancestor ofTTRVal30Met mutation in Italian population and its potential role in genotype-phenotype correlation
P2860
Q26764754-67E55619-E32D-4373-82DD-1C349D876FB4Q28071522-5868D35E-54BE-46D1-9CB2-39001FC9F211Q28078350-22A06D86-8425-4FCE-AC53-67568B101D46Q28086773-3239B420-0D5F-4262-AF7A-F2A08915CADBQ34328734-BEF75787-3008-4A07-AFA3-8D790334E102Q35244195-6DA6708C-9403-484E-B5A3-6DCADD62F1C1Q36295804-17BD22E3-0A60-40F4-B482-9DD91C3B4F13Q36517698-611453F8-A219-431D-9265-22C488BAE660Q36524933-4B00A805-9A56-4F69-917C-82B660C92E2CQ37847929-6BF08E1F-359B-4017-8091-FF2A56DBA184Q37899075-C7BA982F-8F3C-4889-86F3-0440A6D16476Q38001756-400692F0-0FB6-45E4-BFD4-57498971ACDEQ39091511-F3C2F42F-EA05-4ED4-A39A-6A6909684B69Q40532663-B2BA3C9F-E752-46B9-A90E-6C4CA2C6A31BQ41490359-1DCFC29C-1706-4868-974C-C2F4C2B12F5CQ43035071-3493EC81-E46C-413C-A74F-A3CC735C20E1Q43984985-39A44F4A-F142-4208-96DB-A1C3EDF14A73Q44135752-06521E81-D3C1-463D-BAA2-DEBAF7BC6B02Q46533922-E6D933AE-D5B8-4555-B3A9-441D0565A98BQ48489121-BC6C70F2-470F-4983-8395-33EA1EC7E1BEQ58125069-459E5DBA-7AF8-4DE5-B739-641BFE6D6D16Q58187069-11EA28AA-CCC5-4764-9358-0710FF8FD9F6
P2860
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies?
description
im September 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 September 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2006
@uk
name
Phenotypic and genotypic heter ...... ing of therapeutic strategies?
@en
Phenotypic and genotypic heter ...... ing of therapeutic strategies?
@nl
type
label
Phenotypic and genotypic heter ...... ing of therapeutic strategies?
@en
Phenotypic and genotypic heter ...... ing of therapeutic strategies?
@nl
prefLabel
Phenotypic and genotypic heter ...... ing of therapeutic strategies?
@en
Phenotypic and genotypic heter ...... ing of therapeutic strategies?
@nl
P2093
P2860
P50
P1433
P1476
Phenotypic and genotypic heter ...... ing of therapeutic strategies?
@en
P2093
Alessandra Ferlini
Angelo Branzi
Antonio D Pinna
Enrica Perugini
Fabrizio Salvi
Francesca Pastorelli
Francesco Grigioni
Giorgio Arpesella
Ilaria Bartolomei
Letizia Riva
P2860
P304
P356
10.1080/13506120600877136
P407
P577
2006-09-01T00:00:00Z